The New York Node is proud to announce that Dr. John Rotrosen, MD, an esteemed and long-time member of the CTN, has been presented the Lifetime Achievement Award by the National Institute on Drug Abuse (NIDA), in recognition of his unwavering commitment to the advancement of translational research in the area of substance use and other psychiatric disorders. This distinguished honor recognizes his outstanding contributions advancing science that improves lives. Dr. Rotrosen’s contributions to addiction, ADHD, schizophrenia, and movement disorders research have made a significant impact on public health, including the development of atypical antipsychotics, innovative drug delivery methods, and new treatments for SUDs. As a principal investigator for major NIDA and Veterans Administration initiatives, he has led seminal clinical trials and medication development projects using innovative and elegant approaches that leveraged clinical genetics, neuroimaging, and healthcare services research to help bridge the gap between scientific discovery and real-world medical practice, improving addiction treatment accessibility and outcomes. Dr. Rotrosen’s work has not only made a significant impact on the field of addiction but has also inspired and influenced countless individuals in the research community and society at large. Dr. Rotrosen retired in October 2023, after being with the CTN since its inception in 2000. Read more about his retirement here. Congratulations, Dr. Rotrosen!

Congratulations to Judith Tsui, MD, MPH, member of the CTN Pacific Northwest Node, who has just been named the President-Elect of CPDD (College on Problems of Drug Dependence)! Dr. Tsui is a Professor of Medicine at the University of Washington, based at Harborview Medical Center and Evergreen Treatment Services, Director of the UW GIM Substance Use Research and Education (SURE) Unit, Associate Director of the Addiction Medicine Fellowship at the UW, Director of the UW/Fred Hutch Center for AIDS Research Substance Scientific Working Group, and PI/Director of the NIH/NIDA R25-funded UW Medical Student Addiction Research (“MedStAR”) Program. Each director on the CPDD board offers a unique perspective that works to strengthen the strategic direction of the organization and help it continue to grow, innovate, and serve its community with purpose. We know Dr. Tsui will be an invaluable asset to the board and are looking forward to how this new experience will inform the work of the Pacific Northwest Node as well! Read more about the incoming board members here!